HALO
Halozyme Therapeutics Inc
NASDAQ: HALO · HEALTHCARE · BIOTECHNOLOGY
$63.06
-1.25% today
Updated 2026-04-29
Market cap
$7.47B
P/E ratio
24.63
P/S ratio
5.35x
EPS (TTM)
$2.56
Dividend yield
—
52W range
$48 – $82
Volume
1.6M
Halozyme Therapeutics Inc (HALO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.08M | $-147660.00 | $-35.37M | $-40.15M | $-45.39M | $-34.35M | $-64.33M | $-49.34M | $-47.52M | $-37.08M | $-50.38M | $134.05M | $-49.50M | $-85.42M | $55.45M | $299.44M | $240.11M | $388.57M | $479.06M | $651.56M |
| Capital expenditures | $364799.00 | $2.37M | $1.16M | $1.46M | $646544.00 | $828508.00 | $1.41M | $2.30M | $1.37M | $2.36M | $3.14M | $1.35M | $4.66M | $4.04M | $2.50M | $1.46M | $4.81M | $15.29M | $10.70M | $6.97M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $3.70M | $4.53M | $4.87M | $5.57M | $8.35M | $9.54M | $15.27M | $20.84M | $25.59M | $30.67M | $35.70M | $34.78M | $17.20M | $20.82M | $24.40M | $36.62M | $43.38M | $51.56M |
| Free cash flow | $6.71M | $-2.51M | $-36.53M | $-41.61M | $-46.03M | $-35.18M | $-65.74M | $-51.64M | $-48.89M | $-39.44M | $-53.52M | $132.70M | $-54.16M | $-89.46M | $52.95M | $297.98M | $235.30M | $373.28M | $468.37M | $644.59M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $14.22M | $63.39M | $12.54M | — | $13.48M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-30.43M | $47.08M | $-72.14M | $34.03M | $-18.10M | $23.47M | $101.98M | $-110.80M | $62.24M | $27.52M | $-28.98M | $115.48M | — | — | — |